Aperion Biologics, Inc. Stock

Aperion Biologics, Inc. is a commercial-stage medical device company addressing the need for an alternative to human-based sources of tissues to be used in surgical procedures. The Company's lead product, the Z-Lig, is produced by a process for porcine tendons. It has various product families in clinical and preclinical development and research stages that fall into over four general groupings: Z-Lig, Z-Patch, Z-Fix and Z-Meniscus. Its Z-Lig family of devices are used in a range of ligament reconstruction procedures, in addition to the initial application for the anterior cruciate ligament (ACL). Its Z-Patch is an extracellular matrix product used in soft tissue repair and augmentation procedures. Its Z-Fix is a bone-based product for biologic fixation in ACL reconstruction procedures and permits an all-biologic ACL reconstruction. Its Z-Meniscus is a meniscus device, which can be used in the repair or reconstruction of meniscal injuries and defects.